Skip to main content
BIOVENTIX PLC logo

BIOVENTIX PLC — Investor Relations & Filings

Ticker · BVXP ISIN · GB00B4QVDF07 LEI · 213800225MHX7LZQY108 IL Manufacturing
Open in API
Filings indexed 211 across all filing types
Latest filing 2017-01-13 Major Shareholding Noti…
Country GB United Kingdom
Listing IL BVXP

About BIOVENTIX PLC

https://www.bioventix.com/

Bioventix PLC is a biotechnology company that specializes in the development, creation, and commercial supply of high-affinity sheep monoclonal antibodies (SMAs). These antibodies are utilized by global diagnostic companies as critical components in clinical diagnostic platforms, particularly for blood testing immunoassays. The company's portfolio supports a variety of applications, including diagnostics for cardiovascular conditions (troponin), oncology, and neurodegenerative diseases such as Alzheimer's. In addition to its core antibody products, Bioventix also provides ELISA kits for monitoring exposure to industrial pollutants and offers contract services for the development of new SMAs for healthcare organizations.

Recent filings

Filing Released Lang Actions
Bioventix Plc - Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is clearly titled 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' and details changes in shareholding ('An acquisition or disposal of voting rights') by an entity ('CASTLEFIELD FUND PARTNERS LIMITED') in the issuer ('Bioventix Plc'). It specifies the date the threshold was crossed (5%) and the resulting percentage of voting rights (5.197%). This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the code MRQ.
2017-01-13 English
Bioventix Plc - Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is titled 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' and details changes in shareholding ('An acquisition or disposal of voting rights') by 'Wasatch Advisors, Inc.' in 'Bioventix PLC'. It specifies the date the threshold was crossed (3%) and the resulting percentage of voting rights (2.99%). This structure is characteristic of regulatory filings related to insider or major shareholder transactions, specifically those mandated by regulations concerning major shareholdings crossing notification thresholds. This aligns directly with the definition for Major Shareholding Notification (MRQ).
2017-01-05 English
Bioventix Plc - Result of AGM
AGM Information Classification · 99% confidence The document explicitly states in the title and body: "# Bioventix Plc - Result of AGM" and "Bioventix plc announces that at its Annual General Meeting held earlier today, all resolutions put to shareholders were duly passed." This content directly relates to the outcome of the Annual General Meeting (AGM). According to the definitions, materials shared during the AGM, especially the results, fall under AGM Information (AGM-R). The document is short and serves as a notification of the results, fitting the AGM-R category better than a general Regulatory Filing (RNS).
2016-12-07 English
Bioventix Plc - Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'Bioventix Plc - Director/PDMR Shareholding' and details transactions (sales) of ordinary shares by directors (Ian Nicholson, Peter Harrison) and persons closely associated (PCA). This type of mandatory disclosure regarding insider trading or executive share transactions directly corresponds to the definition of Director's Dealing. Filing Definition 9: Director's Dealing (Code: DIRS) - Report of personal share transactions by company directors and executives (insider trades). The content perfectly matches this category.
2016-11-18 English
Bioventix Plc - Notice of AGM
Report Publication Announcement Classification · 99% confidence The document is titled 'Bioventix Plc - Notice of AGM' and explicitly states that the 'Annual General Meeting will be held' on a specific date. It also mentions that copies of the '2016 Annual Report and the Notice of the Annual General Meeting have been sent to shareholders'. Since the document's primary purpose is to announce the AGM details and the availability of the AGM Notice, it strongly aligns with the AGM Information category. Although it mentions the Annual Report, the core subject is the meeting notice itself. Given the short length (2200 chars) and the nature of announcing the meeting and the availability of materials, AGM-R is the most appropriate classification over RPA, as the content is specific to the AGM proceedings.
2016-11-14 English
Full accounts made up to 2016-06-30
Regulatory Filings
2016-11-08 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.